Lista de obras -

A phenotyping algorithm to identify acute ischemic stroke accurately from a national biobank: the Million Veteran Program

artículo científico publicado en 2018

Appropriateness: A Key to Enabling the Use of Genomics in Clinical Practice?

artículo científico publicado en 2016

Are physicians prepared for whole genome sequencing? a qualitative analysis

artículo científico publicado en 2015

Association Between Early Hypertension Control and Cardiovascular Disease Incidence in Veterans With Diabetes

artículo científico publicado en 2019

Can genetic information change patient behavior to reduce Type 2 diabetes risk?

artículo científico publicado en 2013

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

artículo científico publicado en 2008

Comment on: Alssema et al. One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease. Diabetes Care 2012; 35:741-748.

artículo científico publicado en 2012

Comparison of regional body composition and its relation with cardiometabolic risk between BMI-matched young and old subjects.

artículo científico publicado en 2012

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

scientific article published on 01 May 2019

Despite Underestimated Familial Risk by Self-Report, Family History Correlates with Perceived Risk and Worry about Chronic Diseases Such as Coronary Heart Disease and Diabetes.

artículo científico publicado en 2011

Development of a clinical polygenic risk score assay and reporting workflow

artículo científico publicado en 2022

Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults

artículo científico publicado en 2019

Do physicians think genomic medicine will be useful for patient care?

artículo científico publicado en 2014

Efficacy and safety of ginsam, a vinegar extract from Panax ginseng, in type 2 diabetic patients: Results of a double-blind, placebo-controlled study.

artículo científico publicado en 2012

Estimated Filtration: The Continued Need for Expert Classification of Genetic Variants

scientific article published on 27 November 2018

Fried food consumption and risk of coronary artery disease: The Million Veteran Program

scientific article published on 05 June 2019

Genomic testing is best integrated into clinical practice when it is actionable

scientific article published on 04 December 2019

How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19

scientific article published on 07 July 2020

Impact of SLCO1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review

scientific article published on 18 October 2018

Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing.

artículo científico publicado en 2012

Is Genetic testing useful to predict type 2 diabetes? ⬇️

artículo científico publicado el 1 de abril de 2012

Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes.

artículo científico publicado en 2014

NIH working group report-using genomic information to guide weight management: From universal to precision treatment

artículo científico publicado en 2016

Omega-3 supplement use, fish intake, and risk of non-fatal coronary artery disease and ischemic stroke in the Million Veteran Program

scientific article published on 13 March 2019

Palbociclib and Fulvestrant in Breast Cancer

artículo científico publicado en 2019

Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project

artículo científico publicado en 2016

Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee

scientific article published on 01 June 2018

Random plasma glucose predicts the diagnosis of diabetes

scientific article published on 19 July 2019

Reconciling Opportunistic and Population Screening in Clinical Genomics

artículo científico publicado en 2019

Response to Gammal et al

scientific article published on 12 January 2019

Response to comment on Vassy et al. polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 2014;63:2172-2182

artículo científico publicado en 2014

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

article

Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.

artículo científico publicado en 2018

Should You Recommend Direct-to-Consumer Genetic Testing for This Patient? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center

artículo científico publicado en 2020

Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose

artículo científico publicado en 2020

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

artículo científico publicado en 2007

The Integrating Pharmacogenetics in Clinical Care (I-PICC) Study: Protocol for a point-of-care randomized controlled trial of statin pharmacogenetics in primary care

scientific article published on 24 October 2018

The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results

scientific article published on 01 April 2019

Toward greater understanding of patient decision-making around genome sequencing

artículo científico publicado en 2018

When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.

artículo científico publicado en 2017

Yield and bias in defining a cohort study baseline from electronic health record data

artículo científico publicado en 2018

Lista de obras de

A phenotyping algorithm to identify acute ischemic stroke accurately from a national biobank: the Million Veteran Program

Appropriateness: A Key to Enabling the Use of Genomics in Clinical Practice?

Are physicians prepared for whole genome sequencing? a qualitative analysis

Association Between Early Hypertension Control and Cardiovascular Disease Incidence in Veterans With Diabetes

Can genetic information change patient behavior to reduce Type 2 diabetes risk?

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

Comment on: Alssema et al. One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease. Diabetes Care 2012; 35:741-748.

Comparison of regional body composition and its relation with cardiometabolic risk between BMI-matched young and old subjects.

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

Despite Underestimated Familial Risk by Self-Report, Family History Correlates with Perceived Risk and Worry about Chronic Diseases Such as Coronary Heart Disease and Diabetes.

Development of a clinical polygenic risk score assay and reporting workflow

Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults

Do physicians think genomic medicine will be useful for patient care?

Efficacy and safety of ginsam, a vinegar extract from Panax ginseng, in type 2 diabetic patients: Results of a double-blind, placebo-controlled study.

Estimated Filtration: The Continued Need for Expert Classification of Genetic Variants

Fried food consumption and risk of coronary artery disease: The Million Veteran Program

Genomic testing is best integrated into clinical practice when it is actionable

How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19

Impact of SLCO1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review

Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing.

Is Genetic testing useful to predict type 2 diabetes? ⬇️

Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes.

NIH working group report-using genomic information to guide weight management: From universal to precision treatment

Omega-3 supplement use, fish intake, and risk of non-fatal coronary artery disease and ischemic stroke in the Million Veteran Program

Palbociclib and Fulvestrant in Breast Cancer

Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project

Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee

Random plasma glucose predicts the diagnosis of diabetes

Reconciling Opportunistic and Population Screening in Clinical Genomics

Response to Gammal et al

Response to comment on Vassy et al. polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 2014;63:2172-2182

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.

Should You Recommend Direct-to-Consumer Genetic Testing for This Patient? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center

Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

The Integrating Pharmacogenetics in Clinical Care (I-PICC) Study: Protocol for a point-of-care randomized controlled trial of statin pharmacogenetics in primary care

The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results

Toward greater understanding of patient decision-making around genome sequencing

When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.

Yield and bias in defining a cohort study baseline from electronic health record data